Data shows that greater gender diversity on company leadership groups leads to improved business outcomes, says Stanford cardiologist Hannah Valantine.) Likewise, she says, in medical research, where diversity boosts the development of new technologies.
In this episode of Stanford Engineering’s The Future of Everything, Valantine, the former inaugural chief officer for scientific workforce diversity at the National Institutes of Health, as well as a senior investigator at the National Heart, Lung, and Blood Institute, discusses why increasing the diversity of researchers and study participants is vital to medical innovation. Valantine and host, bioengineer Russ Altman), then explore the barriers that keep new medical technologies, such as a blood test to detect signs of heart transplant rejection, from being used in hospitals. Listen and subscribe here).
Connect With Us:
Episode Transcripts >>> The Future of Everything Website)
Connect with Russ >>> Threads) / Bluesky) / Mastodon)
Connect with School of Engineering >>>Twitter/X) / Instagram) / LinkedIn) / Facebook)
